High Purity 2-Amino-4,5-bis(2-methoxyethoxy)benzoic Acid Ethyl Ester Hydrochloride for Erlotinib Synthesis

Discover the critical pharmaceutical intermediate, 2-Amino-4,5-bis(2-methoxyethoxy)benzoic Acid Ethyl Ester Hydrochloride (CAS: 183322-17-0), essential for the production of Erlotinib, a leading antineoplastic agent. We are a trusted manufacturer and supplier, offering high-quality products for your drug development needs.

Get a Quote & Sample

Key Advantages of Our Pharmaceutical Intermediate

Uncompromised Purity for Pharmaceutical Use

Our 2-Amino-4,5-bis(2-methoxyethoxy)benzoic acid ethyl ester hydrochloride (CAS: 183322-17-0) undergoes rigorous quality control to ensure exceptional purity, making it ideal for the synthesis of active pharmaceutical ingredients like Erlotinib.

Reliable Supply Chain and Manufacturing

We are a trusted manufacturer in China, committed to providing a consistent and dependable supply of this critical pharmaceutical intermediate. Partner with us for uninterrupted production of your oncology drugs.

Cost-Effective Sourcing for Your Business

By choosing us as your supplier, you gain access to competitively priced, high-quality 2-Amino-4,5-bis(2-methoxyethoxy)benzoic acid ethyl ester hydrochloride, optimizing your procurement costs and enhancing business profitability.

Applications in Pharmaceutical Development

Erlotinib Synthesis

This compound is a fundamental building block in the multi-step synthesis of Erlotinib, a targeted therapy for various cancers. We ensure the quality required for this critical pharmaceutical application.

Oncology Drug Development

It plays a crucial role in the research and development of novel antineoplastic agents, supporting the advancement of cancer treatments and improving patient outcomes.

Pharmaceutical Intermediate

Beyond Erlotinib, this versatile intermediate can be explored for the synthesis of other complex organic molecules within the pharmaceutical sector. Purchase from our reliable supply.

Research and Development

We supply this compound for R&D purposes, enabling scientists and researchers to explore new synthetic pathways and drug candidates in the field of oncology.